abstract |
This invention relates to compounds according to the general formula (I), where the definitions of the substituents R1, R2, Ar and X are as specified in the description, and to their physiologically tolerated salts, methods for the preparation of these compounds and their use as medicaments. n nThese compounds are poly(ADP-ribose) polymerase (PARP) inhibitors. |